Mentors in this theme are MD and PhD scientists who translate diabetes basic and systems research into strategies for directly helping patients.
Mentors in this Group
Nathan Cherrington, PhD.
Dr. Cherrington investigates drug metabolism and disposition, with a special focus on liver damage including hepatic and renal ontogeny, non-alcoholic steatohepatitis, and adverse drug reactions.
Geoffrey Gurtner, MD.
Dr. Gurtner utilizes a wide range of cutting-edge technologies to advance wound healing, regeneration, and foreign body response.
Kenneth Liechty, MD.
Dr. Liechty focuses on healing, the response to injury, and regenerative medicine, with an emphasis on elucidating the mechanisms involved in the regenerative response to injury in the fetus, the role of stem cells in tissue repair, and the correction of abnormal healing in the adult.
Rick Schnellmann, PhD.
Dr. Schnellmann’s research focuses on identifying and developing drugs to treat diabetic kidney disease, acute kidney injury, stroke, spinal cord injury and Parkinson’s disease.
Jason Wertheim MD,PhD.
Dr. Wertheim's research centers on biomedical engineering and biomaterials for tissue engineering, investigating the growth/differentiation of cells into mature liver, kidney and vascular tissue within biomaterial scaffolds to model disease or develop cells for transplantation emphasizing diabetic kidney disease.